EHU096301
MISSION® esiRNA
targeting human CXADR
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.51
UNSPSC Code:
41105324
description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
CCAGCCAGATCAAGGATGTAGTATCTCATAGTTCCCAGGTGATATTTTTCTTATTAGAAAAATATTATAACTCATTTGTTGTTTGACACTTATAGATTGAAATTTCCTAATTTATTCTAAATTTTAAGTGGTTCTTTGGTTCCAGTGCTTTATGTTGTTGTTGTTTTTGGATGGTGTTACATATTATATGTTCTAGAAACATGTAATCCTAAATTTACCCTCTTGAATATAATCCCTGGATGATATTTTTTATCATAAATGCAGAATAATCAAATACATTTTAAGCAAGTTAAGTGTCCTCCATCAATTCTGTATTCCAGACTTGGGAGGATGT
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
General description
MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Azadeh Nilchian et al.
Cancer research, 79(1), 47-60 (2018-11-06)
Tight junctions (TJ) act as hubs for intracellular signaling pathways controlling epithelial cell fate and function. Deregulation of TJ is a hallmark of epithelial-mesenchymal transition (EMT), which contributes to carcinoma progression and metastasis. However, the signaling mechanisms linking TJ to
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EHU096301-20UG | 04061828587377 |
| EHU096301-50UG | 04061828352845 |